SHARON HOSPITAL
1. Target Overview & Investment Thesis
SHARON HOSPITAL is a 66-bed under-performing / distressed in LITCHFIELD, CT with $47.0M in net patient revenue and a -55.0% operating margin. The hospital serves a payer mix of 49.3% Medicare, 10.1% Medicaid, and 40.7% commercial.
Thesis: Turnaround. Our ML models identify $3.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -55.0% to -47.6% (+736bps).
| Net Revenue HCRIS | $47.0M |
| Current EBITDA COMPUTED | $-25.8M |
| Operating Margin COMPUTED | -55.0% |
| Occupancy HCRIS | 17.5% |
| Revenue / Bed COMPUTED | $712K |
| Net-to-Gross HCRIS | 37.8% |
| Distress Probability ML | 59.5% |
2. Market Context & Competitive Position
CT has 39 Medicare-certified hospitals with a median operating margin of -6.8%. The target's margin of -55.0% places it below the state median. Among 11 size-comparable peers (33-132 beds), the median margin is -13.0%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (33-132), prioritizing same-state peers. 11 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| SHARON HOSPITAL (Target) | CT | 66 | $47.0M | -55.0% |
| THE GRIFFIN HOSPITAL | CT | 101 | $217.2M | -13.8% |
| CHARLOTTE HUNGERFORD HOSPITAL | CT | 91 | $163.6M | -8.9% |
| BRISTOL HOSPITAL INC | CT | 123 | $146.0M | -6.6% |
| WINDHAM COMMUNITY MEMORIAL HOS | CT | 46 | $123.7M | 5.6% |
| DAY KIMBALL HOSPITAL | CT | 104 | $106.6M | -12.3% |
| JOHNSON MEMORIAL HOSPITAL INC | CT | 44 | $65.6M | -20.4% |
| SILVER HILL HOSPITAL | CT | 35 | $45.2M | -16.6% |
| NATCHAUG HOSPITAL | CT | 59 | $42.2M | -32.2% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.5M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $986K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $939K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $930K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $572K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $30K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-25.8M |
| + RCM Uplift | +$3.5M |
| Pro Forma EBITDA | $-22.4M |
| Current Margin | -55.0% |
| Pro Forma Margin | -47.6% |
| WC Released (1x) | $1.8M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-39.7M | $-135.8M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-39.7M | $-162.3M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-35.8M | $-163.8M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-35.8M | $-189.2M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-43.7M | $-140.2M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-43.7M | $-168.4M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Low occupancy | At 17.5%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 59.5% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 11 hospitals with 33-132 beds
- Same-state prioritization (n=12)
- Comp margins: P25=-19.5% / P50=-13.0% / P75=-9.0%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.